Pharmacist Removed from Register for Unlawful Supply of Controlled Drugs Leading to Patient’s Death
Date of Decision: January 17, 2025
Registrant's Role: Pharmacist
Allegations:
- Supply of Zopiclone and Zolpidem, both Class C controlled drugs, without a prescription
- Falsification of records related to drug supply
- Failure to report concerns regarding the misuse of controlled drugs
- Lack of insight and failure to take responsibility for actions
Outcome: Removal from the GPhC register
GPhC Standards Breached:
- Standard 1 – Provide person-centred care
- Standard 2 – Work in partnership with others
- Standard 3 – Communicate effectively
- Standard 5 – Use professional judgment
- Standard 6 – Behave in a professional manner
- Standard 8 – Speak up when things go wrong
- Standard 9 – Demonstrate leadership
Case Summary
The General Pharmaceutical Council (GPhC) investigated the registrant following their conviction for the unlawful supply of controlled drugs. The case stemmed from an investigation initiated after the sudden death of a patient, Person A, in August 2020.
The police examined Person A’s phone and found extensive WhatsApp conversations between her and the registrant, indicating that she had been obtaining Zopiclone and Zolpidem from the registrant without a valid prescription. Her husband, Person B, later approached the registrant under the pretext of purchasing medication and confirmed that he was able to buy controlled drugs for cash, without any prescription.
The registrant was subsequently arrested and charged with:
Continue Reading the Full Case
This case was published more than two weeks ago. A premium subscription is required to read the complete case summary.
- Full allegations considered by the GPhC/PSNI
- Panel findings and reasoning
- Outcome of the investigation
- Sanctions considered and imposed on the Pharmacist
- Key professional learning points
Original Case Document
The original determination document is available to registered users.